Indefinite for non-invasive neoplasia lesions in gastric intestinal metaplasia: The immunophenotype

Journal of Clinical Pathology

Volumn 60, Issue 6, 2007, Pages 615-621

  Cassaro, Mauro ^a,c   Rugge, Massimo ^a,b   Tieppo, Chiara ^a   Giacomelli, Luciano ^c   Velo, Daniela ^a   Nitti, Donato ^a   Farinati, Fabio ^d  

^a UNIVERSITY OF PADOVA   (Italy)

^b VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

^c UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^d R Farini Gastroenterology Unit ^*

Author keywords

[No Author keywords available]

Indexed keywords

KI 67 ANTIGEN; PROCASPASE 3; TELOMERASE REVERSE TRANSCRIPTASE; TRANSCRIPTION FACTOR CDX2;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER CLASSIFICATION; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; GASTROINTESTINAL TRACT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOPHENOTYPING; MALE; METAPLASIA; NEOPLASM; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCORING SYSTEM; WORLD HEALTH ORGANIZATION;

ADULT; AGED; AGED, 80 AND OVER; CASPASE 3; FEMALE; GASTRIC MUCOSA; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HOMEODOMAIN PROTEINS; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOPHENOTYPING; MALE; METAPLASIA; MIDDLE AGED; NEOPLASM PROTEINS; OBSERVER VARIATION; PRECANCEROUS CONDITIONS; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS; TELOMERASE; TUMOR MARKERS, BIOLOGICAL; UBIQUITIN-PROTEIN LIGASES;

EID: 34250847636     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.2006.040386     Document Type: Article

References (34)

1. Fenoglio-Preiser C, Carneiro F, Correa P, et al. Gastric carcinoma. In: Hamilton SR, Aaltonen LA, eds. Pathology and genetics, tumors of the digestive system. Lyon, France: IARC Press, 2000:39-52.
2. Rugge M, Correa P, Dixon MF, et al. Gastric dysplasia: the Padova International Classification. Am J Surg Pathol 2000;24:167-76.
3. Rugge M, Leandro G, Farinati F, et al. Gastric epithelial dysplasia. How clinicopathologic background relates to management. Cancer 1995;76:376-82.
4. Rugge M, Farinati F, Baffa R, et al. Gastric epithelial dysplasia in the natural history of gastric cancer: a multicenter prospective follow-up study. Interdisciplinary Group on Gastric Epithelial Dysplasia. Gastroenterology 1994;107:1288-96.
5. Rugge M, Cassaro M, Di Mario F, et al. The long term outcome of gastric non-invasive neoplasia. Gut 2003;52:1111-16.
6. Igarashi N, Takahashi M, Ohkubo H, et al. Predictive value of Ki-67, p53 protein and DNA content in the diagnosis of gastric carcinoma. Cancer 1999;86:1449-54.
7. Shipper D, Wagenmans MJM, Peters WHM, et al. Significance of cell proliferation measurement in gastric cancer. Eur J Cancer 1998;34:781-90.
8. Testino G, Gada D, De Iaco F, et al. p53 and Ki-67 expression in epithelial gastric dysplasia and in gastric cancer. Panminerva Med 2002;44:369-71.
9. Silberg DG, Swain GP, Suh ER, et al. Cdx1 and Cdx2 expression during intestinal development. Gastroenterology 2000;119:961-71.
10. Seno H, Oshima M, Taniguchi MA, et al. Cdx2 expression in the stomach with intestinal metaplasia and intestinal-type cancer: prognostic implications. Int J Oncol 2002;21:769-74.
11. Rugge M, Ingravallo G, Farinati F, et al. Cdx2 homeotic gene expression in gastric noninvasive neoplasia. Am J Surg Pathol 2004;28:834-5.
12. Maruyama Y, Hanai H, Fujita M, et al. Telomere length and telomerase activity in carcinogenesis of the stomach. Jpn J Clin Oncol 1997;27:216-20.
13. Tang R, Cheng AJ, Wang J, et al. Close correlation between telomerase expression and adenomatous polyp progression in multistep colorectal carcinogenesis. Cancer Res 1998;58:4052-4.
14. Yan P, Saraga EP, Bouzourene H, et al. Telomerase activation in colorectal carcinogenesis. J Pathol 1999;189:207-12.
15. Feng RH, Zhu ZG, Li JF, et al. Inhibition of human telomerase in MKN-45 cell line by antisense hTR expression vector induces cell apoptosis and growth arrest. World J Gastroenterol 2002;8:436-40.
16. Krajewska M, Wang HG, Krajewski S, et al. Immunohistochemical analysis of in vivo pattern of expression of CPP32 (Caspase-3), a cell death protease. Cancer Res 1997;57:1605-13.
17. Shanmugathasan M, Jothy S. Apoptosis, anoikis and their relevance to the pathobiology of colon cancer. Pathol Int 2000;50:273-9.
18. Zhivotovsky B, Samali A, Gahm A, et al. The intracellular localization and translocation during apoptosis. Cell Death Differ 1999;6:644-51.
19. Ramuz O, Isnardon D, Devilard E. Constitutive nuclear localization and initial cytoplasmic apoptotic activation of endogenous caspase-3 evidenced by confocal microscopy. Int J Exp Path 2003;84:75-81.
20. Isobe N, Onodera H, Mori A, et al. Caspase-3 expression in human gastric carcinoma and its clinical significance. Oncology 2004;66:201-9.
21. Dixon MF, Genta RM, Yardley JH, et al. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996;20:1161-81.
22. Genta RM. Recognizing atrophy: another step toward a classification of gastritis. Am J Surg Pathol 1996;20(Suppl 1):S23-30.
23. Rugge M, Genta RM. Staging gastritis: an international proposal. Gastroenterology 2005;129:1807-8.
24. Rugge M, Genta RM. Staging and grading of chronic gastritis. Hum Pathol 2005;36:228-33.
25. Dowall JE, Willis P, Prescott R, et al. Cell proliferation in type C gastritis affecting the intact stomach. J Clin Pathol 2000;5310:784-7.
26. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;33:159-74.
27. Correa P. The biological model of gastric carcinogenesis. IARC Sci Publ 2004;157:301-10.
28. Garcia SB, Park HS, Novelli M, et al. Field cancerization, clonality, and epithelial stem cells: the spread of mutated clones in epithelial sheets. J Pathol 1999;187:61-81.
29. Mizoshita T, Inada K, Tsukamoto T, et al. Expression of Cdx1 and Cdx2 mRNAs and relevance of this expression to differentiation in human gastrointestinal mucosa with special emphasis on participation in intestinal metaplasia of the human stomach. Gastric Cancer 2001;4:185-91.
30. Brittan M, Wright NA. Stem cell in gastrointestinal structure and neoplastic development. Gut 2004;53:899-910.
31. Loeffler M, Grossmann B. A stochastic branching model with formation of subunits applied to the growth of intestinal crypts. J Theor Biol 1991;150:175-91.
32. Weinstein WM, Goldstein NS. Gastric dysplasia and its management. Gastoenterology 1994;107:1543-5.
33. Itskowitz SH, Harpaz N. Diagnosis and management of dysplasia in patients with inflammatory bowel diseases. Gastroenterology 2004;126:1634-48.
34. Robert ME. Defining dysplasia in Barrett esophagus. J Clin Gastroenterol 2003;36(Suppl5):S19-25.